![]() |
|
|
Vol. 30, Issue 12, 1478-1483, December 2002
Drug Metabolism and Drug Disposition Group, University of
Saskatchewan, Saskatoon, Saskatchewan, Canada
Two of the abundant conjugates of human nicotine metabolism result
from the N-glucuronidation of
S-(
)-nicotine and S-(
)-cotinine, transformations we recently demonstrated in liver microsomes. We
further studied these microsomal N-glucuronidation
reactions with respect to human hepatic interindividual, human
intertissue, and interspecies hepatic variation. The reactivities of
microsomes from human liver (n = 12), various human
tissues, and liver from eight species toward the
N-glucuronidation of S-(
)-nicotine and S-(
)-cotinine, and also R-(+)-nicotine
in human liver were examined. Assays with 14C-labeled
substrates involved radiometric high-performance liquid chromatography.
For the human liver samples examined there were 13- to 17-fold
variations in the catalytic activities observed toward
S-(
)-nicotine, R-(+)-nicotine, and
S-(
)-cotinine. Gender and smoking effects were
studied, and after exclusion of an outlier a decrease in catalytic
activity in females was observed. Significant correlations were
observed between all three analytes, indicating that the same
UDP-glucuronosyltransferase(s) enzyme is likely to be involved in these
transformations. Catalytic activities were not observed for human
gastrointestinal tract (colon, duodenum, ileum, jejunum, and stomach),
kidney, or lung microsomes. For the seven animal species examined,
activity was measurable only for monkey, guinea pig, and minipig, and
only for S-(
)-nicotine N-glucuronidation and at rates 10- to 40-fold lower than
humans. Activity was not measurable in the case of dog, mouse, rabbit, or rat, for the latter under five different treatment conditions for
one of the strains. In conclusion, there are large hepatic interindividual variations in N-glucuronidation of
S-(
)-nicotine and S-(
)-cotinine, in
human extrahepatic metabolism seems limited, and none of the animal
strains examined resembled human.
This article has been cited by other articles:
![]() |
G. I. Somers, N. Lindsay, B. M. Lowdon, A. E. Jones, C. Freathy, S. Ho, A. J. M. Woodrooffe, M. K. Bayliss, and G. R. Manchee A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes Drug Metab. Dispos., October 1, 2007; 35(10): 1797 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaivosaari, P. Toivonen, L. M. Hesse, M. Koskinen, M. H. Court, and M. Finel Nicotine Glucuronidation and the Human UDP-Glucuronosyltransferase UGT2B10 Mol. Pharmacol., September 1, 2007; 72(3): 761 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. K. Siu and R. F. Tyndale Characterization and Comparison of Nicotine and Cotinine Metabolism in Vitro and in Vivo in DBA/2 and C57BL/6 Mice Mol. Pharmacol., March 1, 2007; 71(3): 826 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, P. Jacob III, and N. L. Benowitz Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Kuehl and S. E. Murphy N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., November 1, 2003; 31(11): 1361 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuuranne, M. Kurkela, M. Thevis, W. Schanzer, M. Finel, and R. Kostiainen GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., September 1, 2003; 31(9): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||